{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:56:58Z","timestamp":1789790218442,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1078985"],"award-info":[{"award-number":["1078985"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00204-020-02709-2","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T08:02:49Z","timestamp":1584172969000},"page":"1763-1768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clusterin is regulated by IGF1\u2013PI3K signaling in the heart: implications for biomarker and drug target discovery, and cardiotoxicity"],"prefix":"10.1007","volume":"94","author":[{"given":"Sebastian","family":"Bass-Stringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Y. Y.","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,14]]},"reference":[{"issue":"11","key":"2709_CR1","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/S1470-2045(17)30605-8","volume":"18","author":"TM Beer","year":"2017","unstructured":"Beer TM, Hotte SJ, Saad F, Alekseev B, Matveev V, Flechon A, Gravis G, Joly F, Chi KN, Malik Z, Blumenstein B, Stewart PS, Jacobs CA, Fizazi K (2017) Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial. Lancet Oncol 18(11):1532\u20131542. https:\/\/doi.org\/10.1016\/S1470-2045(17)30605-8","journal-title":"Lancet Oncol"},{"issue":"43","key":"2709_CR2","doi-asserted-by":"publisher","first-page":"17615","DOI":"10.1073\/pnas.1206432109","volume":"109","author":"BC Bernardo","year":"2012","unstructured":"Bernardo BC, Gao XM, Winbanks CE, Boey EJ, Tham YK, Kiriazis H, Gregorevic P, Obad S, Kauppinen S, Du XJ, Lin RC, McMullen JR (2012) Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci USA 109(43):17615\u201317620. https:\/\/doi.org\/10.1073\/pnas.1206432109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2709_CR3","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1096\/fj.14-253856","volume":"28","author":"BC Bernardo","year":"2014","unstructured":"Bernardo BC, Nguyen SS, Winbanks CE, Gao XM, Boey EJ, Tham YK, Kiriazis H, Ooi JY, Porrello ER, Igoor S, Thomas CJ, Gregorevic P, Lin RC, Du XJ, McMullen JR (2014) Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy. FASEB J 28(12):5097\u20135110. https:\/\/doi.org\/10.1096\/fj.14-253856","journal-title":"FASEB J"},{"key":"2709_CR4","doi-asserted-by":"publisher","first-page":"22442","DOI":"10.1038\/srep22442","volume":"6","author":"BC Bernardo","year":"2016","unstructured":"Bernardo BC, Nguyen SS, Gao XM, Tham YK, Ooi JY, Patterson NL, Kiriazis H, Su Y, Thomas CJ, Lin RC, Du XJ, McMullen JR (2016) Inhibition of miR-154 protects against cardiac dysfunction and fibrosis in a mouse model of pressure overload. Sci Rep 6:22442. https:\/\/doi.org\/10.1038\/srep22442","journal-title":"Sci Rep"},{"issue":"3","key":"2709_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1042\/CS20171269","volume":"132","author":"BC Bernardo","year":"2018","unstructured":"Bernardo BC, Weeks KL, Pongsukwechkul T, Gao X, Kiriazis H, Cemerlang N, Boey EJH, Tham YK, Johnson CJ, Qian H, Du XJ, Gregorevic P, McMullen JR (2018) Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodelling. Clin Sci (Lond) 132(3):381\u2013397. https:\/\/doi.org\/10.1042\/CS20171269","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"2709_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S1470-2045(17)30168-7","volume":"18","author":"KN Chi","year":"2017","unstructured":"Chi KN, Higano CS, Blumenstein B, Ferrero JM, Reeves J, Feyerabend S, Gravis G, Merseburger AS, Stenzl A, Bergman AM, Mukherjee SD, Zalewski P, Saad F, Jacobs C, Gleave M, de Bono JS (2017) Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial. Lancet Oncol 18(4):473\u2013485. https:\/\/doi.org\/10.1016\/S1470-2045(17)30168-7","journal-title":"Lancet Oncol"},{"issue":"1","key":"2709_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/BJ20061489","volume":"404","author":"SI Gharbi","year":"2007","unstructured":"Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, Timms JF, Waterfield MD (2007) Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J 404(1):15\u201321. https:\/\/doi.org\/10.1042\/BJ20061489","journal-title":"Biochem J"},{"key":"2709_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081194","author":"A Hoter","year":"2019","unstructured":"Hoter A, Rizk S, Naim HY (2019) The multiple roles and therapeutic potential of molecular chaperones in prostate cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11081194","journal-title":"Cancers (Basel)"},{"issue":"13","key":"2709_CR9","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1128\/MCB.01240-07","volume":"28","author":"H Jo","year":"2008","unstructured":"Jo H, Jia Y, Subramanian KK, Hattori H, Luo HR (2008) Cancer cell-derived clusterin modulates the phosphatidylinositol 3'-kinase-Akt pathway through attenuation of insulin-like growth factor 1 during serum deprivation. Mol Cell Biol 28(13):4285\u20134299. https:\/\/doi.org\/10.1128\/MCB.01240-07","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2709_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3858\/emm.2011.43.1.006","volume":"43","author":"HO Jun","year":"2011","unstructured":"Jun HO, Kim DH, Lee SW, Lee HS, Seo JH, Kim JH, Kim JH, Yu YS, Min BH, Kim KW (2011) Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt\/GSK-3beta signaling pathway. Exp Mol Med 43(1):53\u201361. https:\/\/doi.org\/10.3858\/emm.2011.43.1.006","journal-title":"Exp Mol Med"},{"issue":"1","key":"2709_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jacl.2016.11.009","volume":"11","author":"L Koller","year":"2017","unstructured":"Koller L, Richter B, Winter MP, Sulzgruber P, Potolidis C, Liebhart F, Mortl D, Berger R, Goliasch G, Lang I, Wojta J, Hulsmann M, Niessner A (2017) Clusterin\/apolipoprotein J is independently associated with survival in patients with chronic heart failure. J Clin Lipidol 11(1):178\u2013184. https:\/\/doi.org\/10.1016\/j.jacl.2016.11.009","journal-title":"J Clin Lipidol"},{"key":"2709_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fphys.2019.00362","volume":"10","author":"N Kurgan","year":"2019","unstructured":"Kurgan N, Noaman N, Pergande MR, Cologna SM, Coorssen JR, Klentrou P (2019) Changes to the human serum proteome in response to high intensity interval exercise: a sequential top-down proteomic analysis. Front Physiol 10:362. https:\/\/doi.org\/10.3389\/fphys.2019.00362","journal-title":"Front Physiol"},{"issue":"4","key":"2709_CR13","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/ATVBAHA.109.201988","volume":"30","author":"RC Lin","year":"2010","unstructured":"Lin RC, Weeks KL, Gao XM, Williams RB, Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD, Mollica JP, Speirs HJ, Dawes IW, Daly RJ, Shioi T, Izumo S, Febbraio MA, Du XJ, McMullen JR (2010) PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA. Arterioscler Thromb Vasc Biol 30(4):724\u2013732. https:\/\/doi.org\/10.1161\/ATVBAHA.109.201988","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2709_CR14","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3892\/mmr.2012.1110","volume":"6","author":"X Ma","year":"2012","unstructured":"Ma X, Bai Y (2012) IGF-1 activates the P13K\/AKT signaling pathway via upregulation of secretory clusterin. Mol Med Rep 6(6):1433\u20131437. https:\/\/doi.org\/10.3892\/mmr.2012.1110","journal-title":"Mol Med Rep"},{"issue":"21","key":"2709_CR15","doi-asserted-by":"publisher","first-page":"12355","DOI":"10.1073\/pnas.1934654100","volume":"100","author":"JR McMullen","year":"2003","unstructured":"McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, Izumo S (2003) Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci USA 100(21):12355\u201312360. https:\/\/doi.org\/10.1073\/pnas.1934654100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2709_CR16","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1074\/jbc.M310405200","volume":"279","author":"JR McMullen","year":"2004","unstructured":"McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, Bisping E, Schinke M, Kong S, Sherwood MC, Brown J, Riggi L, Kang PM, Izumo S (2004) The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J Biol Chem 279(6):4782\u20134793. https:\/\/doi.org\/10.1074\/jbc.M310405200","journal-title":"J Biol Chem"},{"issue":"2","key":"2709_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1073\/pnas.0606663104","volume":"104","author":"JR McMullen","year":"2007","unstructured":"McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, Mollica JP, Zhang L, Zhang Y, Shioi T, Buerger A, Izumo S, Jay PY, Jennings GL (2007) Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 104(2):612\u2013617. https:\/\/doi.org\/10.1073\/pnas.0606663104","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2709_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10741-017-9654-z","volume":"23","author":"RM Pereira","year":"2018","unstructured":"Pereira RM, Mekary RA, da Cruz Rodrigues KC, Anaruma CP, Ropelle ER, da Silva ASR, Cintra DE, Pauli JR, de Moura LP (2018) Protective molecular mechanisms of clusterin against apoptosis in cardiomyocytes. Heart Fail Rev 23(1):123\u2013129. https:\/\/doi.org\/10.1007\/s10741-017-9654-z","journal-title":"Heart Fail Rev"},{"issue":"3","key":"2709_CR19","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2353\/ajpath.2009.090126","volume":"175","author":"L Pretorius","year":"2009","unstructured":"Pretorius L, Du XJ, Woodcock EA, Kiriazis H, Lin RC, Marasco S, Medcalf RL, Ming Z, Head GA, Tan JW, Cemerlang N, Sadoshima J, Shioi T, Izumo S, Lukoshkova EV, Dart AM, Jennings GL, McMullen JR (2009) Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am J Pathol 175(3):998\u20131009. https:\/\/doi.org\/10.2353\/ajpath.2009.090126","journal-title":"Am J Pathol"},{"issue":"12","key":"2709_CR20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.117.028252","volume":"136","author":"GA Quaife-Ryan","year":"2017","unstructured":"Quaife-Ryan GA, Sim CB, Ziemann M, Kaspi A, Rafehi H, Ramialison M, El-Osta A, Hudson JE, Porrello ER (2017) Multicellular transcriptional analysis of mammalian heart regeneration. Circulation 136(12):1123\u20131139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028252","journal-title":"Circulation"},{"key":"2709_CR21","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1038\/ncomms6705","volume":"5","author":"G Sapra","year":"2014","unstructured":"Sapra G, Tham YK, Cemerlang N, Matsumoto A, Kiriazis H, Bernardo BC, Henstridge DC, Ooi JY, Pretorius L, Boey EJ, Lim L, Sadoshima J, Meikle PJ, Mellet NA, Woodcock EA, Marasco S, Ueyama T, Du XJ, Febbraio MA, McMullen JR (2014) The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice. Nat Commun 5:5705. https:\/\/doi.org\/10.1038\/ncomms6705","journal-title":"Nat Commun"},{"issue":"1","key":"2709_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/sj.cdd.4401779","volume":"13","author":"B Shannan","year":"2006","unstructured":"Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W, Reichrath J (2006) Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 13(1):12\u201319. https:\/\/doi.org\/10.1038\/sj.cdd.4401779","journal-title":"Cell Death Differ"},{"issue":"11","key":"2709_CR23","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1093\/emboj\/19.11.2537","volume":"19","author":"T Shioi","year":"2000","unstructured":"Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, Izumo S (2000) The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19(11):2537\u20132548. https:\/\/doi.org\/10.1093\/emboj\/19.11.2537","journal-title":"EMBO J"},{"issue":"20","key":"2709_CR24","doi-asserted-by":"publisher","first-page":"e010378","DOI":"10.1161\/JAHA.118.010378","volume":"7","author":"V Talman","year":"2018","unstructured":"Talman V, Teppo J, Poho P, Movahedi P, Vaikkinen A, Karhu ST, Trost K, Suvitaival T, Heikkonen J, Pahikkala T, Kotiaho T, Kostiainen R, Varjosalo M, Ruskoaho H (2018) Molecular atlas of postnatal mouse heart development. J Am Heart Assoc 7(20):e010378. https:\/\/doi.org\/10.1161\/JAHA.118.010378","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2709_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1159\/000351207","volume":"59","author":"IP Trougakos","year":"2013","unstructured":"Trougakos IP (2013) The molecular chaperone apolipoprotein J\/clusterin as a sensor of oxidative stress: implications in therapeutic approaches\u2014a mini-review. Gerontology 59(6):514\u2013523. https:\/\/doi.org\/10.1159\/000351207","journal-title":"Gerontology"},{"issue":"6","key":"2709_CR26","doi-asserted-by":"publisher","first-page":"e004838","DOI":"10.1161\/CIRCHEARTFAILURE.117.004838","volume":"11","author":"A Turkieh","year":"2018","unstructured":"Turkieh A, Fertin M, Bouvet M, Mulder P, Drobecq H, Lemesle G, Lamblin N, de Groote P, Porouchani S, Chwastyniak M, Beseme O, Amouyel P, Mouquet F, Balligand JL, Richard V, Bauters C, Pinet F (2018) Expression and implication of clusterin in left ventricular remodeling after myocardial infarction. Circ Heart Fail 11(6):e004838. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004838","journal-title":"Circ Heart Fail"},{"key":"2709_CR27","doi-asserted-by":"publisher","DOI":"10.2174\/1389201020666190821151120","author":"X Wang","year":"2019","unstructured":"Wang X, Yu Y, Zang L, Zhang P, Ma J, Chen D (2019) Targeting clusterin induces apoptosis, reduces growth ability, invasion and mediates sensitivity to chemotherapy in human cancer in human osteosarcoma cells. Curr Pharm Biotechnol. https:\/\/doi.org\/10.2174\/1389201020666190821151120","journal-title":"Curr Pharm Biotechnol"},{"issue":"4","key":"2709_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCHEARTFAILURE.112.966622","volume":"5","author":"KL Weeks","year":"2012","unstructured":"Weeks KL, Gao X, Du XJ, Boey EJ, Matsumoto A, Bernardo BC, Kiriazis H, Cemerlang N, Tan JW, Tham YK, Franke TF, Qian H, Bogoyevitch MA, Woodcock EA, Febbraio MA, Gregorevic P, McMullen JR (2012) Phosphoinositide 3-kinase p110alpha is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction. Circ Heart Fail 5(4):523\u2013534. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.966622","journal-title":"Circ Heart Fail"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-020-02709-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T00:07:17Z","timestamp":1615680437000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-020-02709-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,14]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2709"],"URL":"https:\/\/doi.org\/10.1007\/s00204-020-02709-2","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,14]]},"assertion":[{"value":"21 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}